Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Thermo Fisher (TMO)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN) and Thermo Fisher (TMO).
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Amgen (AMGN)
Bernstein analyst Courtney Breen maintained a Hold rating on Amgen yesterday. The company’s shares closed last Monday at $329.13.
According to TipRanks.com, Breen is a 5-star analyst with an average return of
Amgen has an analyst consensus of Moderate Buy, with a price target consensus of $366.26, representing a 9.9% upside. In a report issued on May 20, TipRanks – DeepSeek also downgraded the stock to Hold with a $349.00 price target.
See the top stocks recommended by analysts >>
Thermo Fisher (TMO)
Bank of America Securities analyst Michael Ryskin maintained a Buy rating on Thermo Fisher today and set a price target of $630.00. The company’s shares closed last Monday at $494.04, close to its 52-week low of $493.30.
According to TipRanks.com, Ryskin is a 3-star analyst with an average return of
Currently, the analyst consensus on Thermo Fisher is a Strong Buy with an average price target of $608.38, representing a 24.2% upside. In a report released yesterday, Wolfe Research also initiated coverage with a Buy rating on the stock with a $535.00 price target.
Read More on AMGN:
